Press Releases
Feb. 23, 2026
Phio Pharmaceuticals Corp. Selected as B2i Digital Featured Company
Neutral
EIN Presswire
Feb. 23, 2026
Beacon Therapeutics to Participate in TD Cowen's 46th Annual Health Care Conference
Indeterminate
GlobeNewswire, Inc.
Feb. 23, 2026
Ultragenyx Pharmaceutical Inc. Securities Class Action Filed; Lead Plaintiff Deadline April 6, 2026 – RGRD Law
Indeterminate
GlobeNewswire, Inc.
Mar. 12, 2026
Just Salad Opens Drive-Thru in Norwalk, Connecticut
Indeterminate
GlobeNewswire, Inc.
Mar. 12, 2026
Elicio Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Updates
Indeterminate
GlobeNewswire, Inc.
Mar. 11, 2026
Gourmet All-Day Café Toastique to Reopen in El Paso Under New Ownership
Neutral
EIN Presswire
Feb. 19, 2026
SCAN Health Plan Surges Into the Top 10 of Medicare Advantage Plans Nationally
Neutral
EIN Presswire
Feb. 20, 2026
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire, Inc.
Feb. 20, 2026
UPDATE – AMN Healthcare Announces Fourth Quarter and Full Year 2025 Results
Indeterminate
GlobeNewswire, Inc.
Feb. 19, 2026
AMN Healthcare Announces Fourth Quarter and Full Year 2025 Results
Indeterminate
GlobeNewswire, Inc.
Feb. 18, 2026
Whitehouse Leads Senate Democrats’ Investigation into EPA’s Decision to Disregard Health Impacts in Air Pollution Standards
Gov't Institution
U.S. Senate Committee on Environment and Public Works
Owner: American Government
Mar. 14, 2026
New Alliance Brings Together 1.2 Million Illinois Rare Disease Patients
Neutral
EIN Presswire
Feb. 18, 2026
Bertrand P. Cole, D.O. - 723495 - 02/02/2026
Gov't Institution
U.S. Food and Drug Administration
Owner: American Government